Board Meeting7 Nov 2026, 12:30 pm
Nath Bio-Genes Board Meeting on Nov 14 to Approve Q2 FY27 Results
AI Summary
Nath Bio-Genes (India) Ltd has announced that its Board of Directors will convene on November 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The trading window for the company's shares will remain closed from September 30, 2026, and will reopen on November 17, 2026, in accordance with the code of conduct for the prevention of insider trading.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Trading window closure and reopening dates announced.
- Adherence to insider trading prevention code.
Price Impact
More from NATHBIOGEN